Moleculin Biotech posts corporate presentation on website; no material new details disclosed

Moleculin Biotech, Inc.

Company furnished investor presentation dated January 2026 as Exhibit 99.1.
Presentation posted on company website under Item 7.01 Regulation FD disclosure.
No specific financial or clinical updates provided in the filing text.

item 7.01 item 9.01

Moleculin Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-001484

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.